Cell Cycle/Checkpoint
Cell Cycle
Cells undergo a complex cycle of growth and division that is referred to as the cell cycle. The cell cycle consists of four phases, G1 (GAP 1), S (synthesis), G2 (GAP 2) and M (mitosis). DNA replication occurs during S phase. When cells stop dividing temporarily or indefinitely, they enter a quiescent state called G0.
Targets for Cell Cycle/Checkpoint
- ATM/ATR(26)
- Aurora Kinase(47)
- Cdc42(4)
- Cdc7(4)
- Chk(16)
- c-Myc(20)
- CRM1(8)
- Cyclin-Dependent Kinases(91)
- E1 enzyme(1)
- G-quadruplex(14)
- Haspin(7)
- HMTase(1)
- Kinesin(26)
- Ksp(6)
- Microtubule/Tubulin(243)
- Mps1(15)
- Mitotic(11)
- RAD51(18)
- ROCK(71)
- Rho(13)
- PERK(11)
- PLK(37)
- PTEN(8)
- Wee1(7)
- PAK(21)
- Arp2/3 Complex(8)
- Dynamin(12)
- ECM & Adhesion Molecules(40)
- Cholesterol Metabolism(3)
- Endomembrane System & Vesicular Trafficking(26)
- G1(38)
- G2/M(26)
- G2/S(10)
- Genotoxic Stress(18)
- Inositol Phosphates(18)
- Proteolysis(99)
- Cytoskeleton & Motor Proteins(53)
- Cellular Chaperones(8)
Products for Cell Cycle/Checkpoint
- Cat.No. Product Name Information
- GC19058 BAY1217389 BAY 1217389 is a potent, and selective inhibitor of the monopolar spindle 1 (MPS1) kinase with an IC50 value less than 10 nM.
- GC49757 Bazedoxifene N-oxide An oxidative degradation product of bazedoxifene
- GC46907 Bazedoxifene-d4 An internal standard for the quantification of bazedoxifene
-
GC32868
BDP5290
BDP5290 is a potent inhibitor of ROCK and MRCK with IC50 values of 17nM, 230nM, 123nM and 100nM for MRCKβ, ROCK1, ROCK2, respectively .
- GC49042 Benastatin A A bacterial metabolite with diverse biological activities
- GC49781 Benomyl A carbamate pesticide
- GC49836 Benoxaprofen Benoxaprofen (LRCL 3794) is a potent and long-acting anti-inflammatory and antipyretic compound.
- GC61831 Benproperine phosphate Benproperine phosphate is an orally active, potent actin-related protein 2/3 complex subunit 2 (ARPC2) inhibitor.
- GC49387 Berberine-d6 (chloride) An internal standard for the quantification of berberine
- GC17828 BI-847325 dual inhibitor of MEK and Aurora kinases
- GC11224 BI6727(Volasertib) BI6727(Volasertib) (BI 6727) is an orally active, highly potent and ATP-competitive Polo-like kinase 1 (PLK1) inhibitor with an IC50 of 0.87 nM. BI6727(Volasertib) inhibits PLK2 and PLK3 with IC50s of 5 and 56 nM, respectively. BI6727(Volasertib) induces mitotic arrest and apoptosis. BI6727(Volasertib), a dihydropteridinone derivative, shows marked antitumor activity in multiple cancer models.
- GC42933 Binucleine 2 Binucleine 2 is an isoform-specific and ATP-competitive inhibitor of Drosophila Aurora B kinase (Ki = 0.36 μM), a kinase involved in cell division.
- GC49724 BIO-1211 (trifluoroacetate salt) A peptide inhibitor of α4β1 integrin
- GC42936 Biotin Tripeptide-1 Biotin tripeptide-1 is an extracellular matrix (ECM) peptide that has been conjugated to biotin.
- GC42942 bis-ANS (potassium salt) bis-ANS (potassium salt) is a fluorescent probe of hydrophobic protein.
- GC40060 Blasticidin A Blasticidin A is a bacterial metabolite originally isolated from S.
- GC11648 BML-277 Chk2 inhibitor,potent and highly selective
- GC18408 BML-278 BML-278 is an activator of sirtuin 1 (SIRT1) that has an EC150 value (effective concentration able to increase the enzyme by 150%) of 1 uM.
- GC12865 BMS265246 CDK1/2 inhibitor,potent and selective
- GC68021 BMVC
- GC63977 BMVC2 BMVC2 (o-BMVC) is a bisubstitute carbazole derivative of BMVC. BMVC2 is a G-quadruplex (G4) stabilizer.
- GC34102 BNC105 BNC105 is a tubulin polymerization inhibitor with potent antiproliferative and tumor vascular disrupting properties.
- GC46937 Boc-Glu-OBzl An amino acid-containing building block
-
GC42959
BODIPY 493/503
BODIPY 493/503, a lipophilic fluorescence dye, emits bright green fluorescence has been used extensively for lipid droplet labeling (Ex/Em: 493/503 nm).
-
GC42960
BODIPY 505/515
BODIPY 505/515, a lipophilic fluorescence dye, emits fluorescence has been used extensively for lipid droplet labeling (Ex/Em: 505/515 nm).
-
GC42961
BODIPY 558/568 C12
BODIPY 558/568 C12 is a fatty acid-conjugated fluorescent probe for lipid droplets.
- GC14002 Bohemine CDK inhibitor
- GC32846 BOS-172722 BOS-172722 is an inhibitor of monopolar spindle 1 (MPS1) checkpoint with an IC50 of 11 nM and 63 nM for MPS1 (1 mM ATP) and P-MPS1, respectively. BOS-172722 also has potential for the study of various forms of breast cancer.
- GC46943 Boscalid A broad-spectrum carboxamide fungicide
- GC40009 Bostrycin Bostrycin is an anthraquinone originally isolated from B.
- GC46946 BPC 157 (acetate) A pentadecapeptide with diverse biological activities
- GC42969 bpV(phen) (potassium hydrate) bpV(phen) (potassium hydrate), a insulin-mimetic agent, is a potent protein tyrosine phosphatase (PTP) and PTEN inhibitor with IC50s of 38 nM, 343 nM and 920 nM for PTEN, PTP-β and PTP-1B, respectively.
- GC62128 Bractoppin Bractoppin is a inhibitor of phosphopeptide recognition by the human BRCA1 tBRCT domain with IC50 of 74 nM.
- GC48901 BRD9876 An Eg5 inhibitor
- GC49740 Brevetoxin 3 A neurotoxin
- GC46949 Bromacil An herbicide
- GC12001 BS-181 A selective Cdk7 inhibitor
- GC13690 BS-181 HCl BS-181 HCl is a highly selective CDK7 inhibitor with IC50 of 21 nM, and > 40-fold selective for CDK7 than CDK1, 2, 4, 5, 6, or 9.
- GC33149 BTB-1 A reversible Kif18A inhibitor
- GC46104 Butyric Acid-d7 An internal standard for the quantification of sodium butyrate
- GC42997 Butyrolactone I A secondary metabolite from A
- GC45394 Bz-IEGR-pNA (acetate)
- GC40708 C2 L-erythro Ceramide (d18:1/2:0) C2 L-erythro Ceramide is a bioactive sphingolipid and a cell-permeable analog of naturally occurring ceramides.
- GC40709 C2 L-threo Ceramide (d18:1/2:0) C2 L-threo Ceramide is a bioactive sphingolipid and cell-permeable analog of naturally occurring ceramides.
- GC45616 C6 Urea Ceramide An inhibitor of neutral ceramidase
- GC11765 Cabazitaxel Microtubule associated inhibitor
- GC65575 Cabazitaxel-d6 Cabazitaxel-d6 (XRP6258-d6) is the deuterium labeled Cabazitaxel. Cabazitaxel is a semi-synthetic derivative of the natural taxoid 10-deacetylbaccatin III with potential antineoplastic activity.
- GC45395 Cabazitaxel-d9 Cabazitaxel-d9 is deuterium labeled Cabazitaxel. Cabazitaxel is a semi-synthetic derivative of the natural taxoid 10-deacetylbaccatin III with potential antineoplastic activity.
- GC47018 Cacodylic Acid (sodium salt hydrate) A reagent used in electron microscopy techniques
- GC18315 Calpain Inhibitor VI Calpain inhibitor VI is an inhibitor of the calcium-dependent cysteine proteases u-calpain (calpain-1; IC50 = 7.5 nM) and m-calpain (calpain-2; IC50 = 78 nM).
- GC65935 CAM833 CAM833 is a potent orthosteric inhibitor of the interaction between BRCA2 and RAD51 with a Kd of 366 nM against the ChimRAD51 protein. CAM833 also inhibits RAD51 oligomerization.
- GC43135 Cambendazol Cambendazol is one of the most effective agents for the therapy of human strongyloidiasis and .
- GC43139 Capsanthin Capsanthin is a carotenoid that has been found in red paprika and has diverse biological activities.
- GC18449 Cardanol monoene Cardanol monoene is a phenol found in cashew nut shell liquid that reversibly inhibits tyrosinase with an IC50 value of 56 uM in vitro.
- GC47042 Carfilzomib-d8 An internal standard for the quantification of carfilzomib
- GC16692 Casin GTPase Cdc42 inhibitor
- GC52389 Caveolin-1 (82-101) amide (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt) A synthetic peptide fragment of caveolin-1
- GC43150 CAY10406 CAY10406 is a trifluoromethyl analog of an isatin sulfonamide compound that selectively inhibits caspases 3 and 7.
- GC43154 CAY10443 Mitochondrial release of cytochrome c triggers apoptosis via the assembly of a multimeric complex including caspase-9, Apaf-1, and other components, sometimes called the apoptosome.
- GC40795 CAY10503 CAY10503 is a proapoptotic, antiproliferative compound that is able to arrest cell cycle progression in the G0-G1 phase.
- GC41253 CAY10554 CAY10554 is a potent cyclin-dependent kinase 5 (Cdk5) inhibitor, with IC50s of 64 and 98 nM for Cdk5 and Cdk2, respectively.
- GC41317 CAY10625 Survivin is a cellular protein implicated in cell survival by interacting with and inhibiting the apoptotic function of several proteins including Smac/DIABLO, caspase-3, and caspase-7.
- GC40890 CAY10701 CAY10701 is a 7-deazahypoxanthine analog that prevents microtubule formation, blocking the proliferation of HeLa and MCF-7 cells (GI50s = 22 and 38 nM, respectively).
-
GC43206
CAY10732
CAY10732 functions as a fluorescent agent designed to identify the presence of carbon monoxide.
- GC45405 CAY10737
- GC52245 CAY10792 An anticancer agent
- GC33300 CCB02 CCB02 is a selective CPAP-tubulin interaction inhibitor, binding to tubulin and competing for the CPAP binding site of β-tubulin, with an IC50 of 689 nM, and shows potent anti-tumor activity. CCB02 shows no inhibition on the cell cycle- and centrosome-related kinases, or the phosphorylation status of Aurora A, Plk1, Plk2, CDK2, and CHK1.
- GC14986 CCG-100602 Rho pathway inhibitor
- GC12795 CCG-1423 RhoA inhibitor
- GC38898 CCG-222740 CCG-222740 is an orally active and selective Rho/myocardin-related transcription factor (MRTF) pathway inhibitor. CCG-222740 is also a potent inhibitor of alpha-smooth muscle actin protein expression. CCG-222740 effectively reduces fibrosis in skin and blocks melanoma metastasis.
- GC33006 CCT020312 CCT020312 is a selective EIF2AK3/PERK activator.
- GC18053 CCT241533 A selective Chk2 inhibitor
- GC17105 CCT241533 hydrochloride A selective Chk2 inhibitor
- GC19092 CCT241736 CCT241736 is a potent and orally bioavailable dual FLT3 and Aurora kinase inhibitor, which inhibits Aurora kinases (Aurora-A Kd, 7.5 nM, IC50, 38 nM; Aurora-B Kd, 48 nM), FLT3 kinase (Kd, 6.2 nM), and FLT3 mutants including FLT3-ITD (Kd, 38 nM) and FLT3(D835Y) (Kd, 14 nM).
- GC14772 CCT244747 Potent and selective CHK1 inhibitor
- GC33213 CCT251455 CCT251455 is a potent and selective mitotic kinase monopolar spindle 1 (MPS1) inhibitor with an IC50 of 3 nM.
-
GC18051
CCT251545 analogue, Compound 51
Potent, Selective, orally bioavailable CDK 8/19 Inhibitor
- GC48982 CD532 An inhibitor of Aurora A kinase activity and the Aurora A-N-Myc protein-protein interaction
- GC12425 CDK inhibitor II
- GC43217 CDK/CRK Inhibitor CDK/CRK inhibitor is an inhibitor of cyclin-dependent kinases (CDK) and CDK-related kinases (CRK) with IC50 values ranging from 9-839 nM in vitro.
- GC14294 Cdk1/2 Inhibitor III Cdk1/2 Inhibitor III is a potent CDK1 and CDK2 inhibitor with IC50s of 0.6 nM and 0.5 nM for CDK1/cyclin B and CDK2/cyclin A, respectively. Cdk1/2 Inhibitor III is also a potent CDC2-like kinase 1 (CLK1) and CLK3 inhibitor with IC50s of 8.9 nM and 29.2 nM, respectively.
- GC43219 Cdk2 Inhibitor II The cyclin-dependent kinase 2 (Cdk2) works with cyclins A or E to regulate S phase and G2-M transition during the cell cycle.
-
GC11785
CDK4 inhibitor
CDK4/Cyclin D1 inhibitor
- GC11564 Cdk4/6 Inhibitor IV GP-82996 (CINK4) is a pharmacological inhibitor of CDK4/6. GP-82996 has IC50s of 1.5, 5.6 and 25 μM for CDK4/cyclin D1, CDK6/cyclin D1 and Cdk5/p35, respectively. GP-82996 induces the apoptosis of cancer cells U2OS. GP-82996 can be used in the research of cancer.
- GC15914 CDK7-IN-1 potent and selective CDK7 inhibitor
- GC12871 CDK9 inhibitor
- GC17359 CDK9 inhibitor 2
- GC35651 Cenisertib Cenisertib (AS-703569) is an ATP-competitive multi-kinase inhibitor that blocks the activity of Aurora-kinase-A/B, ABL1, AKT, STAT5 and FLT3. Cenisertib induces major growth-inhibitory effects by blocking the activity of several different molecular targets in neoplastic mast cells (MC). Cenisertib inhibits tumor growth in xenograft models of pancreatic, breast, colon, ovarian, and lung tumors and leukemia.
- GC32688 Centrinone (LCR-263) Centrinone (LCR-263) (LCR-263) is a selective and reversible inhibitor of polo-like kinase 4 (PLK4) with a Ki of 0.16 nM.
- GC32751 Centrinone-B (LCR-323) Centrinone-B (LCR-323) (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.
- GN10780 Cephalomannine
- GC52489 Ceramide (hydroxy) (bovine spinal cord) A sphingolipid
- GC52485 Ceramide (non-hydroxy) (bovine spinal cord) A sphingolipid
- GC52486 Ceramide Phosphoethanolamine (bovine) A sphingolipid
- GC43229 Ceramide Phosphoethanolamines (bovine) Ceramide phosphoethanolamine (CPE) is an analog of sphingomyelin that contains ethanolamine rather than choline as the head group.
- GC47073 Ceramides (hydroxy) A mixture of hydroxy fatty acid-containing ceramides
- GC43230 Ceramides (non-hydroxy) Ceramides are generated from sphingomyelin through activation of sphingomyelinases or through the de novo synthesis pathway, which requires the coordinated action of serine palmitoyl transferase and ceramide synthase.
- GC35654 Ceratamine A Ceratamine A is an antimitotic heterocyclic alkaloid isolated from the marine sponge Pseudoceratina sp., acts as a microtubule-stabilizing agent. Ceratamine A exhibits cytotoxicity against human cancer cell lines.
- GC60688 Cereblon modulator 1 Cereblon modulator 1 (CC-90009) is a first-in-class GSPT1-selective cereblon (CRBN) E3 ligase modulator, acts as a molecular glue.
- GC47074 Cerebroside C A fungal metabolite